Skip to content

Cryoport, Inc.

CYRX· NasdaqCore metricsCIK 1124524

Pharmaceutical preparations551 peers

Last sale
Nov 6, 2026 · +19.23%
Market cap
$968.38M
50.7M shares
Filings
1,014
$50.22M
Q3 2026+12.4% FY25 yoy
-$10.85M
Q3 2026N/M FY25 yoy
-$8.80M
Q3 2026N/M FY25 yoy
-$14.26M
Q3 2026derivedN/M FY25 yoy
-$0.25
Q3 2026N/M FY25 yoy
$279.18M
Q3 2026+633.8% FY25 yoy
$968.38M
—
5.0×
2.0×
-1.94%
—

Twelve months to Sep 30, 2026 · derived

Price

$19.10+123.92%+$10.57past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$176.18MFY 2025
$237.28M0FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$176,177,000reported
FY 20242024-12-31$156,769,000 revisedreported
FY 20232023-12-31$168,662,000 revisedreported
FY 20222022-12-31$237,277,000reported
FY 20202021-12-31$222,608,000reported
FY 20192020-12-31$78,696,000reported
FY 20182019-12-31$33,942,000reported
FY 20172017-12-31$11,954,267reported
FY 20162016-12-31$7,678,816reported
FY 20152015-03-31$3,935,320reported

Capital returns

Dividends and buybacks · FY2020 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$10.01M$10.01M—49.86M sh−0.1%—
FY2022—$37.96M$37.96M—48.34M sh——
FY2021—$0.00$0.00————
FY2020—$0.00$0.00—49.69M sh+24.7%—

Segments

Revenue by Segments, FY2022 to FY2025FY2022Life Science Supply Chain Solutions · FY2022 · $135.18MLife Science Systems · FY2022 · $102.10MFY2023Life Sciences Services · FY2023 · $81.19MLife Sciences Products · FY2023 · $87.47MLife Science Supply Chain Solutions · FY2023 · $145.78MLife Science Systems · FY2023 · $87.47MFY2024Life Sciences Services · FY2024 · $85.34MLife Sciences Products · FY2024 · $71.43MLife Science Supply Chain Solutions · FY2024 · $156.95MLife Science Systems · FY2024 · $71.43MFY2025Life Sciences Services · FY2025 · $101.03MLife Sciences Products · FY2025 · $75.15M
LineFY2025ShareChange
Life Sciences Services$101.03M57%+18.4%
Life Sciences Products$75.15M43%+5.2%
Life Science Supply Chain Solutions———
Life Science Systems———
Total$176.18M

From the 10-K filed Mar 5, 2026CYRX

Pharmaceutical preparations

Cryoport, Inc. is the 90th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cryoport, Inc. · CIK 1124524 · Engraved from SEC EDGAR